The Human Helix
It has been over a century since the term ''genetics'' was first used to describe the science of heredity, whose origins lie in the careful plant breeding experiments of Gregor Mendel. These experiments laid the groundwork for further insights upon which our understanding of genetics is based: the discovery of meiosis and the resulting chromosome theory of inheritance, the isolation of DNA and description of its double helical structure, and the one gene-one enzyme hypothesis. Of course, Mendelian simplicity belied true complexity, with phenomena such as pleiotropy, epistasis, and polygenicity making the science of genetics perhaps not a straightforward one but a powerful source of biological understanding all the same.
Although founded in observations of pea plants and microbes, it was only a matter of time before the science of genetics reached inward to illuminate human biology. It is no surprise that the desire to understand our own genomes and our unique, individual or species-level phenotypes has driven an explosion of interest in human genetics and genomics. Driven by technological advances, both experimental and computational, and the eagerness of individuals to share and understand their personal genome sequences, we are at a tipping point. With the growing applications of genomic medicine in the clinic, the escalating forensic power of DNA, and the availability of millions of patients' genomic data powering unprecedented insights into complex disease, human genetics is booming both in the lab and in society.
In this special issue, we're excited to feature pieces that chart the progress forward by exploring the foundational principles of genetic variation and networks; insights into our evolutionary history and the architecture of disease; and many of the key issues, social and scientific, the community is currently facing. We are honored to be a strong part of this community at Cell, through publishing powerful datasets, innovative methods, and breakthrough discoveries in genomic medicine while maintaining a sharp focus on the importance of data availability, ethical considerations, and transparent methodological reporting. We are committed not only to conveying the most innovative work in human genetics to the research community but also to educating and exciting the public, sharing the story of our species with the world.
What's in a Genome? The human genome is, at its simplest, a collection of doublestranded DNA segments, whose sequence dictates cellular phenotypes. In reality, cellular and organismal phenotypes are influenced by the subnuclear organization of the genome, by proteins that bind and traverse the DNA, and by dynamic mutational programs. For this reason, simply knowing the sequence of a genome is insufficient for understanding how the information it carries will manifest. The Human Genome Project, completed in 2003, was a landmark first step in the quest to provide the blueprint of our cells and ourselves. However, with the initial sequence came the realization that gene identity and regulation would prove extraordinarily complex and that the vast majority of the genome, though technically noncoding, would need to be deciphered as well.
Unfortunately, in the leap from genotype to phenotype, no gene is an island. The expression of genes is a variable affair, regulated by combinatorial interactions between transcription factors and chromatin context. Outside of the genome, myriad gene-environment interactions muddle the picture even further. Indeed, the fundamental sequence complexity of a gene gives way to structural complexity at the transcript level as well as vast functional complexity, including pleiotropic effects and epistatic interactions with other genes and their products. Sequence heterogeneity influences each step in the road from genotype to phenotype.
Mapping Our Diversity
The complexity of the human genome lies not only with its structure and interpretation but also with intra-and inter-individual variation. Although humans begin as single cells with one genetic complement, both mutational and epigenetic processes act during development and beyond to generate organisms with heterogenous genomes and epigenomes throughout their somatic tissues. This intra-individual heterogeneity complicates genetic analyses from a cell-type-and tissue-specificity standpoint and can complicate our understanding of disease.
Beyond each individual, it is obvious to the naked eye that our genomes show substantial species-level variation, with clearly observable phenotypic differences only hinting at the vast array of sequence differences with no discernible phenotypic outcome. This plethora of genetic variation within and between populations is a huge focus of the human genetics community now that sequencing is readily accessible, with large sequencing efforts such as deCODE Iceland, the UK Biobank, All of Us, SG10K, and many others across the globe aiming to catalog our diversity. These efforts are crucial in answering questions about disease genetics as well as our history as a species. Indeed, vast underrepresentation of non-European populations in genetic databases is already leading to skewed outcomes for genomic medicine initiatives. With the appropriate focus and resources, this imbalance should be corrected, and a treasure trove of genetic data can equitably illuminate both population-specific susceptibility variants and broad insights into the etiology of disease. There has been no better human experimentalist than natural evolution.
From Data to Insights
Before the age of genome sequencing, many simple monogenic traits were mapped by classical genetic techniques; however, the causes of complex polygenic as well as rare Mendelian diseases have been difficult to pinpoint. In the current era of wholegenome sequencing, the devil lies not in lack of data, in most cases, but in challenges of interpretation. The field of human genetics has thus also seen a massive shift toward computational innovation and education, and the intricate integration of multiomics datasets is a key focus of contemporary efforts to understand the genetic basis of disease.
With leaps in technology and bioinformatic methodologies, the architecture of some genetic traits and diseases is starting to come into sharper focus. Genome sequencing, now financially accessible, is a powerful tool for diagnosing rare disorders and dissecting their etiologies. Integration of sequencing and functional genomics datasets is illuminating genes and variants with roles in complex polygenic conditions, and the adoption of CRISPR/Cas as a gene editing tool is allowing unprecedented investigation into the effects of specific sequence changes on cellular phenotypes. For certain populations, polygenic risk scores can now stratify individuals by disease susceptibility, and implementation of diagnostic and predictive measures across various diseases in the clinic is moving genomic medicine closer to reality.
Of course, hurdles remain in achieving a full understanding of many traits and diseases, including only nascent insights into how environmental effects impinge on genomic outcomes. On the operational side, limited data availability for certain populations and disease cohorts, computational challenges arising from integrating distinct large datasets and necessary efforts to ensure adherence to privacy requirements all pose challenges in making the jump from information to insight. Despite these obstacles, with our combined knowledge of the genetic basis of disease and ability to manipulate the human genome by gene editing, the decades ahead are sure to prove as scientifically and medically fascinating as they will be contentious.
The Importance of Communication
It is human nature to be curious about oneself, and this fact places in the hands of human geneticists a unique opportunity to communicate about their science with the public and educate people who may not often engage with science. The rapid uptake of consumer genetics services such as 23andMe and Ancestry poignantly illustrates the human fascination with our own identity. This opens a valuable inroad to increasing public awareness of science and the importance of adequate funding and support for those who pursue it. It also highlights the key role of professions like genetic counselors, science communicators, and policy advisors, who have the responsibility to ensure that people truly understand their individual results as well as the broader conclusions deriving from ever-increasing genomic data.
It is likewise essential to highlight the importance of open and honest dialog between scientists and the communities they study and serve, particularly in the fields of population genetics and ancient DNA research. There are fundamental questions of data ownership that stem from studying humans and their ancestors, and a nuanced and respectful interaction with those whose DNA we seek and sequence is essential both before and after research is completed. Indeed, communication skills are perhaps the most undervalued but entirely critical tool for the modern human geneticist, and it is our hope that aspiring scientists will hone these skills to use their scientific knowledge for the greatest good.
With Great Data Comes Great Responsibility
The sea of genetic data now available also raises the key issue of data privacy. With the rise in popularity of consumer genetics, the growing use of clinical sequencing, and the ability of individuals to share their sequence through public repositories, genetic privacy may be a fleeting concept. It is increasingly rare to belong to a family in which no member's genome has been genotyped or sequenced, and this raises general concerns about data ownership and individual privacy. The availability of huge genomic databases makes it possible to identify individuals based on their relatives' DNA sequences, as has been illustrated for forensic DNA evidence. What do these technologiessequencing and data interpretation-mean for individuals within our global society? These are important concerns to keep in mind as our databases grow, and the importance of building public trust in genetic research and its clinical application cannot be underestimated.
It is unfortunate that with the intense excitement surrounding human genetics discoveries can also come misinterpretation, distortion, or misuse of scientific results for personal and political agendas. For example, the Chinese government has been collecting genomic data from the country's Uighur ethnic group, potentially using the data for surveillance and tracking, as reported by the New York Times. The recent appropriation by white supremacists of genetic population differences in lactose tolerance as evidence of genetic superiority is the latest in a long line of examples in which genetic variation is misconstrued by those who wish to highlight our differences. Whether it is the inherent responsibility of those who generate the data to defend the accuracy of its interpretation is a question that strains to be answered in the years ahead. Genetic variation notwithstanding, in the words of Maya Angelou, ''we are more alike, my friends, than we are unalike.''
The Road Ahead It's easy to get lost in the morass of work that has yet to be done to understand the human genome; we still have a long way to go. But the road from pea plants to people has already been paved, and our journey is picking up speed. Just decades ago, the completion of the Human Genome Project was a lofty goal, and today we have the great privilege to bemoan its gaps, errors, and lack of diversity. Although the road ahead may be long, the human genetics community is building increasingly advanced vehicles to deliver us to our destination. At Cell, we eagerly await each twist and turn along the way. But we do not want to be solely passengers; instead, we endeavor to anticipate and clear roadblocks to ease the ride ahead. Hop in; let's get going.
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